Issued Patents All Time
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12053476 | Compounds, compositions and methods for cancer patient stratification and cancer treatment | Timothy A. Lewis, Alex Burgin, Monica Schenone, Xiaoyun Wu, Heidi Greulich +6 more | 2024-08-06 |
| 11976334 | Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease | Gerhard Siemeister, Bernard HÄNDLER, Sven Golfier, Andreas SCHLICKER, Li Liu | 2024-05-07 |
| 11712440 | Predictive markers for ATR kinase inhibitors | Gerhard Siemeister, Li Liu | 2023-08-01 |
| 11690911 | Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors | — | 2023-07-04 |
| 11660301 | Combination of ATR kinase inhibitors with PARP inhibitors | Gerhard Siemeister | 2023-05-30 |
| 11529356 | 2-(morpholin-4-yl)-1,7-naphthyridines | Lars Wortmann, Ulrich Lücking, Julien LEFRANC, Hans Briem, Marcus Koppitz +10 more | 2022-12-20 |
| 11142522 | Compounds, compositions and methods for cancer treatment | Timothy A. Lewis, Xiaoyun Wu, Heidi Greulich, Matthew Meyerson, Manuel Ellermann +4 more | 2021-10-12 |
| 10966986 | Compounds, compositions and methods for cancer patient stratification and cancer treatment | Timothy A. Lewis, Alex Burgin, Monica Schenone, Xiaoyun Wu, Heidi Greulich +6 more | 2021-04-06 |
| 10894784 | Heteroarylbenzimidazole compounds | Volker Schulze, Tobias Heinrich, Florian Prinz, Julien LEFRANC, Jens SCHRÖDER +13 more | 2021-01-19 |
| 10772893 | 2-(morpholin-4-yl)-1,7-naphthyridines | Lars Wortmann, Ulrich Lücking, Julien LEFRANC, Hans Briem, Marcus Koppitz +10 more | 2020-09-15 |
| 10729680 | 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines | Ulrich Lücking, Marcus Koppitz, Julien LEFRANC, Lars Wortmann, Gerhard Siemeister +4 more | 2020-08-04 |
| 10604532 | Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases | Marion Hitchcock, Anne Mengel, Vera Pütter, Gerhard Siemeister, Hans Briem +9 more | 2020-03-31 |
| 10266548 | Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases | Marion Hitchcock, Anne Mengel, Vera Pütter, Gerhard Siemeister, Hans Briem +9 more | 2019-04-23 |
| 10226469 | Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treating lymphomas | Ningshu Liu, Katja Haike, Juliane Paul | 2019-03-12 |
| 10214545 | Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders | Volker Schulze, Knut Eis, Florian Puehler, Ludwig Zorn, Detlev Sülzle +3 more | 2019-02-26 |
| 9999623 | Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treating lymphomas | Ningshu Liu, Katja Haike, Juliane Paul | 2018-06-19 |
| 9993484 | 2-(morpholin-4-yl)-1,7-naphthyridines | Lars Wortmann, Ulrich Lücking, Julien LEFRANC, Hans Briem, Marcus Koppitz +10 more | 2018-06-12 |
| 9682995 | Amino-substituted isothiazoles | Lars Bärfacker, Stefan Prechtl, Gerhard Siemeister, Jens Ackerstaff, Katrin Nowak-Reppel +4 more | 2017-06-20 |
| 9676766 | Triazolopyridines | Volker Schulze, Marcus Koppitz, Dirk Kosemund, Hartmut Schirok, Benjamin Bader +6 more | 2017-06-13 |
| 9670202 | Substituted triazolopyridines | Hartmut Schirok, Volker Schulze, Dirk Kosemund, Hans Briem, Benjamin Bader +3 more | 2017-06-06 |
| 9663510 | Substituted triazolopyridines and their use as TTK inhibitors | Volker Schulze, Dirk Kosemund, Gerhard Siemeister, Detlef STÖCKIGT, Michael Brüning | 2017-05-30 |
| 9586958 | Prodrug derivatives of substituted triazolopyridines | Volker Schulze, Hans-Georg Lerchen, Donald Bierer, Gerhard Siemeister, Philip Lienau +6 more | 2017-03-07 |
| 9555022 | Substituted triazolopyridines | Volker Schulze, Dirk Kosemund, Hartmut Schirok, Benjamin Bader, Philip Lienau +7 more | 2017-01-31 |
| 9549932 | 2-(morpholin-4-yl)-1,7-naphthyridines | Lars Wortmann, Ulrich Lücking, Julien LEFRANC, Hans Briem, Franz VON NUSSBAUM +10 more | 2017-01-24 |
| 9540392 | Thienopyrimidines | Georg Kettschau, Florian Puehler, Knut Eis, Ulrich Klar, Dirk Kosemund +6 more | 2017-01-10 |